Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NTLA | Common Stock | Options Exercise | $47.1K | +2.5K | +119.39% | $18.83 | 4.59K | Oct 11, 2021 | Direct | |
transaction | NTLA | Common Stock | Sale | -$299K | -2.5K | -54.42% | $119.55 | 2.09K | Oct 11, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NTLA | Stock Option (right to buy) | Options Exercise | $0 | -2.5K | -8.93% | $0.00 | 25.5K | Oct 11, 2021 | Common Stock | 2.5K | $18.83 | Direct | F2 |
Id | Content |
---|---|
F1 | The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |
F2 | The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested as to 12,666 shares as of October 11, 2021. |